# Task  B08: Synthesis of a Lassa fever virus inhibitor

> **NIH NIH N01** · RESEARCH TRIANGLE INSTITUTE · 2020 · $14,062

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 10145541
- **Project number:** 272201800002I-P00002-759301900133-1
- **Recipient organization:** RESEARCH TRIANGLE INSTITUTE
- **Principal Investigator:** BRUCE BLOUGH
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $14,062
- **Award type:** —
- **Project period:** 2019-08-21 → 2020-08-20

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10145541

## Citation

> US National Institutes of Health, RePORTER application 10145541, Task  B08: Synthesis of a Lassa fever virus inhibitor (272201800002I-P00002-759301900133-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10145541. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*